Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:HRC

Hill-Rom (HRC) Stock Price, News & Analysis

Hill-Rom logo

About Hill-Rom Stock (NYSE:HRC)

Advanced Chart

Key Stats

Today's Range
$155.96
$155.96
50-Day Range
$155.05
$156.18
52-Week Range
$93.34
$156.22
Volume
N/A
Average Volume
656,912 shs
Market Capitalization
$10.30 billion
P/E Ratio
41.92
Dividend Yield
0.62%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.

Receive HRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hill-Rom and its competitors with MarketBeat's FREE daily newsletter.

HRC Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Here Are The Best 37 Rom-Coms Ever Made
See More Headlines

HRC Stock Analysis - Frequently Asked Questions

Hill-Rom Holdings, Inc. (NYSE:HRC) announced its earnings results on Friday, November, 5th. The medical technology company reported $1.67 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.47 by $0.20. The company's revenue for the quarter was up 13.1% compared to the same quarter last year.

The following companies are subsidiaries of Hill-Rom: Breathe Technologies, Voalte Inc, Mortara Instrument, Tridien Medical, Trumpf Medical Systems Ltd., Welch Allyn Inc., Virtus Inc., and others.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hill-Rom investors own include Steel Dynamics (STLD), Walt Disney (DIS), NVIDIA (NVDA), PayPal (PYPL), Meta Platforms (META) and Bank of America (BAC).

Company Calendar

Last Earnings
11/05/2021
Today
5/10/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:HRC
Previous Symbol
NYSE:HB
Employees
10,000
Year Founded
1929

Profitability

Trailing P/E Ratio
41.92
Forward P/E Ratio
24.22
P/E Growth
N/A
Net Income
$248.50 million
Pretax Margin
10.03%

Debt

Sales & Book Value

Annual Sales
$3.02 billion
Cash Flow
$9.29 per share
Price / Cash Flow
16.79
Book Value
$28.56 per share
Price / Book
5.46

Miscellaneous

Free Float
65,594,000
Market Cap
$10.30 billion
Optionable
Optionable
Beta
0.55

Social Links

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NYSE:HRC) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners